InnoPharmax Inc. (TPEX:4172)
Taiwan · Delayed Price · Currency is TWD 9.13
-0.28 (-2.98%)
Nov 10, 2026, 1:58 PM CST
InnoPharmax Market Cap
InnoPharmax has a market cap or net worth of 1.09 billion as of November 10, 2026. It is the 40,146th most valuable company in the world and the 2,295th biggest in Taiwan. Its market cap has decreased by 41.84% in one year.
Market Cap
1.09B
Enterprise Value
848.33M
Revenue
67.47M
Global Rank
Country Rank
#2,295 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since September 13, 2012, InnoPharmax's market cap has decreased from 1.54B to 1.09B, a decrease of -29.19%. That is a compound annual growth rate of -2.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 1.33B | -26.56% |
| Dec 31, 2025 | 1.81B | 3.38% |
| Dec 31, 2024 | 1.75B | 5.76% |
| Dec 29, 2023 | 1.65B | 62.70% |
| Dec 30, 2022 | 1.02B | -32.67% |
| Dec 30, 2021 | 1.51B | 15.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tien Liang BioTech | 1.65B |
| Johnson Chemical Pharmaceutical Works | 1.60B |
| Anxo Pharmaceutical | 1.18B |
| GeneFerm Biotechnology | 1.14B |
| Excelsior Biopharma | 1.11B |
| Prince Pharmaceutical | 1.05B |
| Original BioMedicals | 965.38M |
| DV Biomed | 881.44M |